Your session is about to expire
← Back to Search
Elder Mistreatment Screening for Geriatric Assessment (MISSED Trial)
N/A
Recruiting
Led By Julia A Hiner, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months after study
Awards & highlights
MISSED Trial Summary
This trial will test if a tool can detect elder mistreatment and help link older adults to care to prevent further harm.
Who is the study for?
This trial is for older adults currently admitted to the MHH-TMC Acute Care of Elders unit who can hear, understand, and answer questions on their own. It's not for those who don't want to participate in research.Check my eligibility
What is being tested?
The study tests if a brief screening tool (NCAEM's EM-SART Pre-Screen) can be used effectively in a hospital setting to detect elder mistreatment and connect patients with geriatric care before they leave the hospital.See study design
What are the potential side effects?
There are no direct medical side effects from participating as it involves answering questions about personal experiences. However, discussing sensitive topics like abuse may cause emotional discomfort.
MISSED Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months after study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months after study
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants who have identified elder mistreatment
Number of units using this NCAEM EM-SART Pre-Screen tool
MISSED Trial Design
1Treatment groups
Experimental Treatment
Group I: NCAEM EM-SART Pre-ScreenExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
902 Previous Clinical Trials
320,839 Total Patients Enrolled
Julia A Hiner, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not want to participate in the research study.
Research Study Groups:
This trial has the following groups:- Group 1: NCAEM EM-SART Pre-Screen
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are additional participants being enrolled in this clinical experiment?
"Clinicaltrials.gov reveals that this study, which was first published on April 1st 2023, is no longer recruiting patients. However, 36 other trials are actively searching for volunteers at the moment."
Answered by AI
Share this study with friends
Copy Link
Messenger